Review the major responsibilities of holding an Investigational New Drug (IND) application.
This webinar recording explores common errors and how to avoid these in your trials.
Upon completion of this continuing education program, attendees should be able to understand and identify:
The requirements set forth by 21CFR312 for IND maintenance
When an IND is required
Learn techniques that can help with IND maintenance
Speaker J. Kaitlin Morrison, PhD, Director of UNC Lineberger Sponsored Clinical Research Assistant Professor of Medicine-Hematology, Lineberger Comprehensive Cancer Center